Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Mar 27;23(6):707-15.
doi: 10.1097/QAD.0b013e328325d115.

Effect of pulmonary tuberculosis on mortality in patients receiving HAART

Daniel Westreich  1 , Patrick MacPhail, Annelies Van Rie, Babatyi Malope-Kgokong, Prudence Ive, Dennis Rubel, Ronan Boulmé, Joseph Eron, Ian Sanne
Affiliations

Effect of pulmonary tuberculosis on mortality in patients receiving HAART

Daniel Westreich et al. AIDS. .

Abstract

Objective: To estimate the effect of ongoing treatment for pulmonary tuberculosis (PTB) at time of initiation of HAART on subsequent risk of death.

Design: Evaluation of an open cohort of 7512 patients who initiated HAART between April 2004 and March 2007 in the Themba Lethu Clinic in Johannesburg, South Africa.

Methods: Mortality hazard ratios were estimated using marginal structural Cox proportional hazards models to control for bias due to both confounding and loss to follow-up. Extensive sensitivity and secondary analyses were performed.

Results: Although the crude hazard ratio for mortality in HAART-treated patients comparing those with and without treated PTB was 1.71 (95% confidence interval 1.31-2.23), the adjusted hazard ratio was 1.06 (95% confidence interval 0.75-1.49), indicating no difference in mortality risk. Similar effects were found when we considered different durations of time between initiation of PTB treatment and HAART, and sensitivity analysis confirmed main results. Secondary analysis suggested that individuals with PTB and other risk factors for death might be at particularly high risk of death during HAART treatment.

Conclusion: The increase in death that we observed among individuals with PTB at the time of HAART initiation appears not to be due to the to the presence of PTB, but instead to confounding factors such as low CD4 cell count, low BMI, and WHO stage IV disease. These results further demonstrate that initiation of HAART soon after initiation of PTB treatment is not likely to put patients at higher risk of death.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Survival curves by treatment status for pulmonary tuberculosis (PTB) at baseline, unadjusted (1a), and reweighted for confounding only (1b), among 7512 individuals initiating HAART in Johannesburg, South Africa between 1 April Number at risk changes due to (primarily) administrative censoring (end of follow-up), and losses to follow-up.
Figure 2
Figure 2
Estimates of adjusted hazard ratios from main analyses 1 and 2 and sensitivity analysis S1-S6. Figure 2 footnote. S1: Pulmonary tuberculosis (PTB) treatment started within 30 days before HAART. S2: PTB treatment started within 30 days before or after HAART. S3: restricted follow-up to first four months of HAART. S4: standardized mortality ratio (effect of the exposure among the exposed). S5: Traditional Cox proportional hazards model. S6: Exposure weights only; no censoring weights.
See this image and copyright information in PMC

Comment in

References

    1. WHO . TB/HIV: A Clinical Manual. Second edition. Geneva: 2004. [(Accessed March 31 2008)].
    1. WHO . Geneva: 2008. [(Accessed 18 April 2008)]. WHO Report 2008. Global tuberculosis control - surveillance, planning, financing. http://www.who.int/tb/publications/global_report/2008/
    1. Badri M, Ehrlich R, Wood R, Pulerwitz T, Maartens G. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. Int J Tuberc Lung Dis. 2001;5:225–232. - PubMed
    1. Mukadi YD, Maher D, Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. Aids. 2001;15:143–152. - PubMed
    1. Nunn P, Brindle R, Carpenter L, et al. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality. Am Rev Respir Dis. 1992;146:849–854. - PubMed

Publication types

MeSH terms

Substances